Statins can also downregulate profibrogenic gene expressions (TGF-β1, α-SMA, and tissue inhibitor of metalloproteinases-1) and protein expression of αSMA in HSCs; thus, it reduces liver fibrosis [53]. Here, TGFB1 is linked to Hepatic fibrosis.